However, a recent study has demonstrated that the occurrence of hepatocellular adenoma was prevented by gene therapy in G6pc-/- mice, despite partial and variable G6Pase activity, but with normalized blood metabolite profiles and glucose tolerance [52]. Here, G6PC1 is linked to hepatocellular adenoma.